In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing: Studies from an acute model

American Journal of Pathology

Volumn 169, Issue 6, 2006, Pages 2137-2147

  Calderon, Boris ^a   Suri, Anish ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; EFFECTOR CELL; ELECTRON MICROSCOPY; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ACUTE DISEASE; ANIMAL; CELL CULTURE; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; IMMUNOLOGY; LEUKOCYTE TRANSFUSION; METHODOLOGY; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; SPLEEN; TRANSGENIC MOUSE;

LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ISLETS OF LANGERHANS; LEUKOCYTE TRANSFUSION; LEUKOCYTES; MACROPHAGES; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SPLEEN;

EID: 34548359992     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060539     Document Type: Article

References (47)

1. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297
2. Kikutani H, Makino S: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992, 51:285-322
3. Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB: The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 1977, 26:100-112
4. Katz J, Benoist C, Mathis D: Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol 1993, 23:3358-3360
5. Mora C, Wong FS, Chang CH, Flavell RA: Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J Immunol 1999, 162:4576-4588
6. Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M: Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Cell Immunol 1993, 148:189-197
7. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M: Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 1992, 22:2387-2393
8. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, Lanier LL: NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004, 20:757-767
9. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway Jr CA, Matis LA: The role of Fas in autoimmune diabetes. Cell 1997, 89:17-24
10. Kägi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H: Reduced incidence and delayed onset of diabetes in perforindeficient nonobese diabetic mice. J Exp Med 1997, 186:989-997
11. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, Kay TW: IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 2004, 53:113-121
12. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C, Rabinovitch A: An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J Autoimmun 2001, 16:449-455
13. Katz JD, Wang B, Haskins K, Benoist C, Mathis D: Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993, 74:1089-1100
14. Suri A, Katz JD: Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunol Rev 1999, 169:55-65
15. Pakala SV, Chivetta M, Kelly CB, Katz JD: In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 1999, 189:1053-1062
16. Suri A, Shimizu J, Katz JD, Sakaguchi S, Unanue ER, Kanagawa O: Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. Eur J Immunol 2004, 34:447-454
17. Lacy PE: Electron microscopy of the normal islets of Langerhans; studies in the dog, rabbit, guinea pig and rat. Diabetes 1957, 6:498-507
18. Lernmark A: The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 1974, 10:431-438
19. Rogers HW, Unanue ER: Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 1993, 61:5090-5096
20. Wipke BT, Allen PM: Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001, 167:1601-1608
21. Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N: In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 1981, 127:34-38
22. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T: In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature 1981, 291:334-335
23. Mule JJ, Krosnick JA, Rosenberg SA: IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. J Immunol 1989, 142:726-733
24. Ballas ZK, Rasmussen W: Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations. J Immunol 1990, 144:386-395
25. van Rooijen N, van Kesteren-Hendrikx E: "In vivo" depletion of macrophages by liposome-mediated "suicide." Methods Enzymol 2003, 373:3-16
26. Van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994, 174:83-93
27. Lacy PE, Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39
28. Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. Edited by R Coico. Hoboken, John Wiley & Sons, Inc., 1998, pp 3.11.14-13.11.17
29. Lee KU, Amano K, Yoon JW: Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 1988, 37:989-991
30. Reddy S, Liu W, Elliott RB: Distribution of pancreatic macrophages preceding and during early insulitis in young NOD mice. Pancreas 1993, 8:602-608
31. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA: Immunohistochemical characterization of monocytesmacrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994, 43:667-675
32. Reddy S, Wu D, Swinney C, Elliott RB: Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 1995, 11:16-25
33. Rosmalen JG, Martin T, Dobbs C, Voerman JS, Drexhage HA, Haskins K, Leenen PJ: Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. Lab Invest 2000, 80:23-30
34. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999, 189:347-358
35. Chung YH, Jun HS, Kang Y, Hirasawa K, Lee BR, Van Rooijen N, Yoon JW: Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J Immunol 1997, 159:466-471
36. Lee KU, Pak CY, Amano K, Yoon JW: Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the depletion of macrophages. Diabetologia 1988, 31:400-402
37. Oschilewski U, Kiesel U, Kolb H: Administration of silica prevents diabetes in BB-rats. Diabetes 1985, 34:197-199
38. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988, 37:930-935
39. Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW: Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice. Diabetes 1999, 48:34-42
40. Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA: Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 2000, 96:2834-2840
41. van Lent PL, Holthuysen AE, van Rooijen N, van de Loo FA, van de Putte LB, van den Berg WB: Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis. J Rheumatol 1998, 25:1135-1145
42. Fox A, Koulmanda M, Mandel TE, van Rooijen N, Harrison LC: Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 1998, 66:1407-1416
43. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, 172:1025-1033
44. Schwizer RW, Leiter EH, Evans R: Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. Transplantation 1984, 37:539-544
45. Appels B, Burkart V, Kantwerk-Funke G, Funda J, Kolb-Bachofen V, Kolb H: Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol 1989, 142:3803-3808
46. Kolb H, Burkart V, Appels B, Hanenberg H, Kantwerk-Funke G, Kiesel U, Funda J, Schraermeyer U, Kolb-Bachofen V: Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmun 1990, 3(Suppl 1):S117-S120
47. Kanagawa O, Shimizu J, Vaupel BA: Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. J Immunol 2000, 164:5466-5473